title: [value of bone densitometry in pediatric renal transplantation].
abstract: OBJECTIVE
  Renal transplantation improves many bone abnormalities inherent to chronic renal insufficiency, but also introduces new deleterious factors, especially those related to immunosuppressive drugs. We have studied the bone mineral content of 40 pediatric renal transplant recipients; moreover, we have analyzed its possible relationships with phosphorous-calcium metabolism, graft function and duration, steroid treatment and growth.
  
  
  METHODS
  Bone mineral content was measured by dual energy X-ray absorptiometry (DEXA). The results were expressed as a z score in relation to age and sex. Immunosuppression was achieved by using triple therapy: azathioprine, cyclosporine A and prednisolone. At the time of the DEXA, 59% of the patients were on daily steroid treatment and 41% on alternate-day treatment.
  
  
  RESULTS
  All patients presented bone mass losses with a maximal decrease between 5 and 21 months post-transplantation and a posterior tendency to recovery. Fifty percent of the children had severe osteopenia (bone mineral density < -1 SD). There was no statistically significant association between the severity of bone loss and values of ionized calcium, phosphorus, intact PTH, or calcitriol received. However, a linear correlation was found between cumulative steroid dose and osteopenia (r = -0.35, p < 0.05). Height and growth velocity were more affected in the severe osteopenia group. In this group, the proportion of children on daily steroid treatment was statistically higher (72% vs 45%, p < 0.05).
  
  
  CONCLUSIONS
  Bone densitometry is an accurate, rapid and noninvasive method to measure renal transplant impact on the growing skeleton and it must be done in a periodic and standardized way.
authors.affiliation: Sección de Nefrología Pediátrica, Hospital Infantil La Paz, Madrid.
authors.forename: M
authors.initials: M
authors.lastname: Melgosa Hijosa
authors.forename: M D
authors.initials: MD
authors.lastname: Romero de Paz
authors.forename: M C
authors.initials: MC
authors.lastname: García Meseguer
authors.forename: A
authors.initials: A
authors.lastname: Alonso Melgar
authors.forename: J
authors.initials: J
authors.lastname: Coya
authors.forename: M
authors.initials: M
authors.lastname: Navarro
mesh_terms: D000293:Adolescent; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D001824:Body Constitution; D015519:Bone Density; D001851:Bone Diseases, Metabolic / Q000139:chemically induced / Q000175:diagnosis; D001862:Bone Resorption / Q000139:chemically induced / Q000175:diagnosis; D002648:Child; D003720:Densitometry; D004305:Dose-Response Relationship, Drug; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy; D006801:Humans; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation; D008297:Male; D013256:Steroids
chemical_list: D000893:Anti-Inflammatory Agents; D013256:Steroids
vernacular_title: Valor de la densitometría ósea en el trasplante renal pediátrico.